Skip to main content
. 2022 Jan 25;12:1309. doi: 10.1038/s41598-022-05334-4

Figure 1.

Figure 1

Transcriptional activity and DNA binding of FOXO1 Nt and DBD mutants. (A) Schematic structure of the human FOXO1 protein and the studied point mutations. (B) HEK293T cells were co-transfected with wild-type or mutated pCMV-FOXO1, luciferase reporter (DBE6x, FOXO1 promoter, HBP1 promoter) and the pEF-β-galactosidase vector as internal control. After 24 h of transfection, cells were lysed to measure the luminescence and the β-galactosidase activity. Average of 3 independent experiments is shown with standard error of the mean. Statistical analysis was calculated according to bilateral Student t-test (*, p < 0.05; **, p < 0.01; ***, p < 0.001). (C) Electrophoretic mobility shift assays (EMSA) were performed using nuclear extracts from HEK293T cells transfected with wild-type or mutated pCMV-FOXO1. A 32P-labeled oligonucleotide probe containing the FOXO consensus DNA-binding sequence (GTAAACA) was added to each nuclear extract. In addition, expression of FOXO1 was analyzed by western blot with an anti-FOXO1 antibody. Original unprocessed images are available in Supplementary Fig. S2.